SUGAR LAND, Texas (AP) — SUGAR LAND, Texas (AP) — Tvardi Therapeutics, Inc. (TVRD) on Thursday reported a loss of $5.5 million in its third quarter.
On a per-share basis, the Sugar Land, Texas-based company said it had a loss of 59 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVRD at https://www.zacks.com/ap/TVRD
